Covered recipient · General Payments record
CHINWENDU LOVELINE IGWE
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2021–2022
$187.64
- Reported across 10 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2022 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $133.35 | 7 |
| Education | $12.14 | 1 |
By paying entity
PY2022 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| AKEBIA THERAPEUTICS INC | $46.46 | 2 |
| CALLIDITAS THERAPEUTICS US INC. | $31.53 | 1 |
| Acerta Pharma LLC | $28.94 | 2 |
| BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | $14.30 | 1 |
| Relypsa, Inc. | $12.14 | 1 |
| Otsuka America Pharmaceutical, Inc. | $12.12 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2022 (8)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AKEBIA THERAPEUTICS INC | $11.64 | 03/15/2022 | Food and Beverage | Undisputed | 01/23/2026 | 885314343 | CMS |
| AKEBIA THERAPEUTICS INC | $34.82 | 04/08/2022 | Food and Beverage | Undisputed | 01/23/2026 | 885314345 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.98 | 06/07/2022 | Food and Beverage | Undisputed | 01/23/2026 | 914740501 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.96 | 07/05/2022 | Food and Beverage | Undisputed | 01/23/2026 | 915840931 | CMS |
| Biohaven Pharmaceutical Holding Company Ltd. | $14.30 | 10/16/2022 | Food and Beverage | Undisputed | 01/23/2026 | 923860669 | CMS |
| CALLIDITAS THERAPEUTICS US INC. | $31.53 | 12/15/2022 | Food and Beverage | Undisputed | 01/23/2026 | 927070103 | CMS |
| Otsuka America Pharmaceutical, Inc. | $12.12 | 08/16/2022 | Food and Beverage | Undisputed | 01/23/2026 | 929406293 | CMS |
| Vifor Pharma, Inc. | $12.14 | 05/24/2022 | Education | Undisputed | 01/23/2026 | 896768377 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022
- Source files
- Dataset page · Bulk file · PY2021 , PY2022
- Generated from
- OP_DTL_GNRL_PGYR2022_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.